{"id":19879,"date":"2021-07-12T15:59:00","date_gmt":"2021-07-12T13:59:00","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=19879"},"modified":"2021-07-21T13:49:43","modified_gmt":"2021-07-21T11:49:43","slug":"khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/","title":{"rendered":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces the publication of new research in <em>PLOS<\/em> <em>ONE<\/em> examining the <em>in vivo <\/em>active metabolite of sonlicromanol, as a selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1)-mediated PGE<sub>2<\/sub> synthesis in prostate cancer stem cells and its potential as a novel treatment approach for prostate cancer and other cancers with high mPGES-1 expression.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sonlicromanol (KH176) is Khondrion\u2019s wholly-owned investigational lead asset, currently in phase IIb development as a potentially disease-modifying treatment for mitochondrial disease. The Company has <a href=\"https:\/\/www.nature.com\/articles\/s41598-020-79466-w\">previously<\/a> demonstrated the ability of sonlicromanol\u2019s active metabolite to selectively inhibit mPGES-1, a key enzyme involved in the production of prostaglandin E<sub>2<\/sub>. This prostaglandin, known to induce and propagate the inflammation response, was found in significantly increased levels in cells derived from mitochondrial disease patients. Importantly, the aggressiveness of cancers, like prostate cancer, has also been found in independent studies to be associated with elevated expression of mPGES-1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The new research, authored by Khondrion, details the effects of selective mPGES-1 targeting by sonlicromanol\u2019s active metabolite, and examines its potential to decrease the aggressiveness of prostate cancer by inhibiting mPGES-1 expression.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The research team found that inhibition of mPGES-1 by sonlicromanol\u2019s metabolite was able to considerably reduce spheroid growth in the human prostate cancer cell line DU145, potentially offering a novel approach in treating prostate cancer and other malignancies with high expression of mPGES-1. Sonlicromanol\u2019s active metabolite was found to reduce the constitutively high mPGES-1 levels. The growth of spheroids in a physiological relevant 3D environment for tumour cells was reduced and the prostate cancer stem cell population was selectively decreased. These findings are of particular interest as they further strengthen earlier research indicating the potential of sonlicromanol [human plasma exposure at steady-state: active metabolite = \u00bd KH176] as a treatment for patients with high mPGES-1 expression and signal its potential as an anti-tumour drug, based on its ability to decrease the size of cancer stem cell-formed spheroids.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Dr. Herma Renkema<\/strong><strong>, Chief Early Development Officer at Khondrion and co-author of the paper, said: <\/strong><em>\u201cThese are significant findings that build on our earlier research into the anti-inflammatory effect of sonlicromanol and its potential as a disease-modifying drug for patients with mitochondrial disease. That research led us to explore the potential of this compound beyond mitochondrial disease, given what we know about its mode of action. Inhibition of mPGES-1 expression is an approach currently being investigated to identify new therapeutic avenues for prostate cancer, which is the most frequently diagnosed cancer in the Western world and the leading cause of cancer-related death in men over 65 years of age. Our research provides compelling evidence to support further studies investigating the potential of sonlicromanol as an anti-tumour drug in prostate and other human cancers.\u201d<\/em><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A link to the study \u2013 Jiang, X., Renkema, H., Smeitink, J., Beyrath J<em>.<\/em> Sonlicromanol\u2019s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth. <em>PLoS ONE<\/em> 16(7): e0254315 (2021) \u2013 can be found here: <a href=\"https:\/\/doi.org\/10.1371\/journal.pone.0254315\">https:\/\/doi.org\/10.1371\/journal.pone.0254315<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Source: Khondrion (<a href=\"https:\/\/www.khondrion.com\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/\">Press release<\/a>)<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces the publication of new research in PLOS ONE examining the in vivo active metabolite of sonlicromanol, as a selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1)-mediated PGE2 synthesis in prostate cancer stem cells and its potential as a novel treatment approach [&hellip;]<\/p>\n","protected":false},"author":16,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-19879","post","type-post","status-publish","format-standard","hentry","category-gezondheid"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces the publication of new research in PLOS ONE examining the in vivo active metabolite of sonlicromanol, as a selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1)-mediated PGE2 synthesis in prostate cancer stem cells and its potential as a novel treatment approach [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-12T13:59:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-21T11:49:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"HollandBIO\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"HollandBIO\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/\"},\"author\":{\"name\":\"HollandBIO\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\"},\"headline\":\"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite\",\"datePublished\":\"2021-07-12T13:59:00+00:00\",\"dateModified\":\"2021-07-21T11:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/\"},\"wordCount\":538,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Gezondheid\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/\",\"name\":\"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2021-07-12T13:59:00+00:00\",\"dateModified\":\"2021-07-21T11:49:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/48824449f08e494bb7ea02e1ff5dd6ea\",\"name\":\"HollandBIO\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/","og_locale":"en_US","og_type":"article","og_title":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio","og_description":"Khondrion, a clinical-stage biopharmaceutical company discovering and developing therapies targeting mitochondrial disease, today announces the publication of new research in PLOS ONE examining the in vivo active metabolite of sonlicromanol, as a selective inhibitor of microsomal prostaglandin E synthase-1 (mPGES-1)-mediated PGE2 synthesis in prostate cancer stem cells and its potential as a novel treatment approach [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/","og_site_name":"hollandbio","article_published_time":"2021-07-12T13:59:00+00:00","article_modified_time":"2021-07-21T11:49:43+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"HollandBIO","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"HollandBIO","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/"},"author":{"name":"HollandBIO","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea"},"headline":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite","datePublished":"2021-07-12T13:59:00+00:00","dateModified":"2021-07-21T11:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/"},"wordCount":538,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Gezondheid"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/","name":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2021-07-12T13:59:00+00:00","dateModified":"2021-07-21T11:49:43+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/khondrion-announces-publication-in-plos-one-of-new-research-showing-normalisation-of-prostate-cancer-stem-cell-mpges-1-overexpression-and-inhibition-of-cancer-spheroid-growth-by-sonlicromanol\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Khondrion announces publication in PLOS ONE of new research showing normalisation of prostate cancer stem cell mPGES-1 overexpression and inhibition of cancer spheroid growth by sonlicromanol\u2019s active metabolite"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/48824449f08e494bb7ea02e1ff5dd6ea","name":"HollandBIO"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=19879"}],"version-history":[{"count":0,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/19879\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=19879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=19879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=19879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}